from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0735/sigL

LFCtreatmentdescriptionclass of inhibitor

1.173

Amikacinug/mL Amikacintranslation

0.182

Cap5-10ug/mL Capreomycintranslation

1.517

Rox10-50 ug/mL Roxithromycintranslation

0.195

SM2-5 ug/mL Streptomycintranslation

1.515

Tet5-10 ug/mL Tetracyclinetranslation

0.478

Rif0.2-5ug/mL Rifampicintranscription

-0.070

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.489

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.137

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.259

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.542

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.666

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.468

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.507

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.156

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.307

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.033

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.239

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.787

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.616

KCN5-20 ug/mL Potassium cyaniderespiration

0.460

NaN30.2-2 mM Sodium aziderespiration

-1.072

Nigericin50 uM Nigericinrespiration

1.962

TRC10-150 ug/mL Triclosanrespiration

-0.212

TRZ10-25 ug/mL Thioridazinerespiration

0.271

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.540

menadione6-10 ug/mL Menadionerespiration

-0.525

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.584

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.032

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.770

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.793

NRP_1Non-replicating persistence stage 1dosRassociated

-0.589

Amp0.2mg/mL AmpicillincellWall

-0.546

Cephalexin20-100 ug/mL CephalexincellWall

-0.824

Cerulenin0.32-5 ug/mL CerulenincellWall

0.096

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.392

EMB10-20 ug/mL EthambutolcellWall

-0.895

Eta12-40 ug/mL EthionamidecellWall

-0.918

INH0.2-0.4 ug/mL IsoniazidcellWall

0.792

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.938

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.137

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.332

BZA0.12 mg/mL BenzamidearomaticAmides

1.160

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.653

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.335

H2O24 mM hydrogen peroxideDNAdamaging

-0.823

Levo10 ug/mL LevofloxacinDNAdamaging

-0.357

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.360

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.362

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.565

UVUV-irradiationDNAdamaging

-0.105

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.841

Antimycin12.5-50 ug/mL Antimycin A?

1.314

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.218

PA_110-50 ug/mL Antitubercular compound PA-1?

0.104

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.156

PA8240.2-2 ug/mL PA-824?

0.745

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.075

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.658

Verapamil50 uM Verapamil?

-0.786

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.227

methoxatin10-20 ug/mL Methoxatin?